Andreas Engert Selected Research

Andreas Engert Research Topics

Disease

151	Hodgkin Disease (Hodgkin's Disease) 10/2022 - 01/2002
75	Neoplasms (Cancer) 01/2022 - 01/2002
37	Lymphoma (Lymphomas) 06/2022 - 01/2002
19	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2021 - 06/2002
16	Infections 08/2022 - 01/2002
9	Anemia 01/2016 - 01/2005
7	Febrile Neutropenia 12/2015 - 08/2003
7	Multiple Myeloma 10/2015 - 03/2006
6	Residual Neoplasm 10/2021 - 07/2005
6	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 02/2009 - 11/2002
5	Fever (Fevers) 01/2021 - 11/2002
5	Neutropenia 10/2018 - 08/2003
5	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2017 - 03/2006
5	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 10/2016 - 11/2003
4	Fatigue 12/2018 - 05/2010
4	Disease Progression 10/2018 - 12/2010
4	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 10/2017 - 03/2014
4	Pathologic Complete Response 12/2011 - 03/2006
3	Hematologic Neoplasms (Hematological Malignancy) 02/2019 - 07/2012
3	Breast Neoplasms (Breast Cancer) 12/2015 - 04/2003
3	Carcinoma (Carcinomatosis) 06/2014 - 04/2003
3	Infertility (Sterility) 01/2008 - 07/2005
2	Second Primary Neoplasms (Neoplasms, Second) 01/2020 - 01/2017
2	Exanthema (Rash) 12/2018 - 09/2016
2	Sclerosis 12/2017 - 06/2007
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2017 - 03/2014
2	Long Term Adverse Effects 01/2017 - 02/2011
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 12/2015 - 05/2006
2	Thrombocytopenia (Thrombopenia) 12/2015 - 11/2002
2	Nausea 04/2015 - 02/2011
2	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 06/2009 - 09/2004
2	B-Cell Lymphoma (Lymphoma, B Cell) 06/2008 - 06/2004

Drug/Important Bio-Agent (IBA)

32	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2021 - 01/2002
27	Bleomycin (Blenoxane)FDA LinkGeneric 11/2021 - 01/2002
25	Cyclophosphamide (Cytoxan)FDA LinkGeneric 06/2021 - 01/2002
24	Prednisone (Sone)FDA LinkGeneric 06/2021 - 01/2002
23	Vincristine (Oncovin)FDA LinkGeneric 06/2021 - 01/2002
20	Procarbazine (Matulane)FDA Link 06/2021 - 01/2002
19	Etoposide (VP 16)FDA LinkGeneric 06/2021 - 01/2002
17	Rituximab (Mabthera)FDA Link 01/2020 - 11/2002
15	Brentuximab VedotinIBA 01/2022 - 06/2012
15	Monoclonal AntibodiesIBA 12/2018 - 01/2003
14	Dacarbazine (DIC)FDA LinkGeneric 11/2021 - 01/2002
14	Vinblastine (Vinblastine Sulfate)FDA Link 11/2021 - 01/2002
11	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 02/2016 - 08/2003
10	Pharmaceutical PreparationsIBA 10/2019 - 08/2003
9	AntibodiesIBA 01/2022 - 04/2003
8	NivolumabIBA 01/2021 - 09/2016
8	LigandsIBA 12/2018 - 03/2006
7	Methotrexate (Mexate)FDA LinkGeneric 12/2020 - 01/2002
6	Proteins (Proteins, Gene)FDA Link 01/2022 - 03/2006
6	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 05/2006
6	Erythropoietin FDA Link 12/2012 - 01/2005
5	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022 - 12/2005
5	AntigensIBA 01/2022 - 04/2003
5	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 02/2016 - 08/2003
4	Immune Checkpoint InhibitorsIBA 09/2017 - 01/2016
4	PanobinostatIBA 01/2017 - 06/2012
4	HematinicsIBA 02/2016 - 12/2008
4	Colony-Stimulating Factors (Colony Stimulating Factor)IBA 02/2016 - 01/2009
4	Alemtuzumab (Campath)FDA Link 02/2012 - 10/2005
4	Gemcitabine FDA Link 12/2011 - 06/2004
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 04/2009
3	Cytarabine (Cytosar-U)FDA LinkGeneric 12/2020 - 02/2010
3	Immunoconjugates (Immunoconjugate)IBA 12/2017 - 07/2014
3	CytokinesIBA 12/2014 - 01/2013
3	pixantrone (BBR 2778)IBA 04/2011 - 08/2003
3	Antineoplastic Agents (Antineoplastics)IBA 07/2009 - 01/2005
3	Biological ProductsIBA 06/2009 - 10/2007
3	fludarabineIBA 01/2009 - 11/2002
3	Hemoglobins (Hemoglobin)IBA 04/2005 - 01/2005
2	Cell-Free Nucleic AcidsIBA 10/2021 - 09/2017
2	Vitamin D FDA LinkGeneric 12/2019 - 11/2017
2	Histone Deacetylase InhibitorsIBA 02/2019 - 01/2013
2	EnzymesIBA 02/2019 - 04/2003
2	Lenalidomide (CC 5013)FDA Link 01/2019 - 02/2010
2	Lipase (Acid Lipase)FDA Link 10/2018 - 09/2016
2	pembrolizumabIBA 01/2017 - 01/2017
2	ChemokinesIBA 05/2014 - 06/2009
2	Cetuximab (Erbitux)FDA Link 03/2014 - 03/2010
2	Natural Killer Cell ReceptorsIBA 04/2013 - 08/2009
2	Interleukin-10 (Interleukin 10)IBA 01/2013 - 11/2008
2	Epoetin Alfa (Epogen)FDA Link 05/2010 - 05/2006
2	NF-kappa B (NF-kB)IBA 08/2009 - 09/2005
2	Adrenal Cortex Hormones (Corticosteroids)IBA 07/2008 - 06/2004
2	PlasticsIBA 05/2008 - 04/2003

Therapy/Procedure

80	Drug Therapy (Chemotherapy) 08/2022 - 01/2002
48	Radiotherapy 11/2021 - 01/2002
42	Therapeutics 01/2022 - 01/2002
19	Stem Cell Transplantation 09/2016 - 12/2005
14	Immunotherapy 01/2017 - 03/2002
7	Erythrocyte Transfusion 02/2016 - 01/2005
6	Aftercare (After-Treatment) 10/2021 - 01/2008
6	Combination Drug Therapy (Combination Chemotherapy) 12/2017 - 06/2004
2	Combined Modality Therapy 11/2021 - 01/2002
2	Induction Chemotherapy 05/2016 - 12/2005
2	Blood Transfusion (Blood Transfusions) 02/2016 - 04/2005
2	Transplantation 10/2015 - 08/2005
2	Autologous Transplantation 10/2015 - 09/2011
2	Chemoradiotherapy 01/2009 - 07/2004